Rubbish speculation. Nice bpharma. Of course it is speculation.
My old man was asking me about share prices an hour before he passed. While the brain is still working it keeps thinking about what it always has.
That $350k purchase was extraordinary, especially with the delta between what he paid and this CR. The money came from somewhere. Suggest given a family business, he got some help to purchase thru the family plus they agreed to up his rem if he bought on market and supported the price. Yes just speculation but must have been something more in it for him given he already has so much of his wealth tied up here.
The CR was always going to be at a hefty discount with current market conditions. Think tactics like this have helped support the price and resulted in less of a fire sale than otherwise.
however they have managed to keep the SP from the 90% drops we have seen on other clinical bios, they have done well.
- Forums
- ASX - By Stock
- Ann: Appendix 4E and Unaudited Preliminary Report
RCE
recce pharmaceuticals ltd
Add to My Watchlist
6.15%
!
30.5¢

Rubbish speculation. Nice bpharma. Of course it is speculation....
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.5¢ |
Change
-0.020(6.15%) |
Mkt cap ! $87.95M |
Open | High | Low | Value | Volume |
32.5¢ | 33.0¢ | 30.5¢ | $54.63K | 174.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 22588 | 30.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.5¢ | 28921 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 22588 | 0.305 |
5 | 27836 | 0.300 |
2 | 10000 | 0.295 |
11 | 90433 | 0.290 |
2 | 135000 | 0.285 |
Price($) | Vol. | No. |
---|---|---|
0.315 | 28921 | 1 |
0.340 | 24538 | 1 |
0.350 | 30000 | 2 |
0.375 | 8002 | 1 |
0.380 | 6820 | 2 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online